GlassScriptPhysician profile
Michael J Sacca
NPI 1275553547
$4,401.01
in general payments reported to CMS, 2019-2025
22 companies · $437 in 2025
The $437 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303 · 2020: $118 · 2021: $369 · 2022: $1,076 · 2023: $509 · 2024: $1,590 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,757 · Travel and Lodging: $779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,756.84 |
| Travel and Lodging | $778.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,954.74 | 2021-2025 | Endurant Iis, Valiant Captivia, Endo Gia Ultra |
| Silk Road Medical, INC. | $867.68 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Nuvasive, INC. | $265.19 | 2022 | |
| Janssen Pharmaceuticals, INC | $262.76 | 2019-2024 | Xarelto |
| Medtronic Vascular, INC. | $228.38 | 2019-2020 | |
| Penumbra, INC. | $154.57 | 2025 | Indigo System |
| Lemaitre Vascular, INC. | $113.58 | 2019-2025 | Artegraft Vascular Graft |
| Tela Bio, INC. | $94.65 | 2024 | Ovitex 2s |
| Innocoll Pharmaceuticals Limited | $75.30 | 2021 | |
| Stryker Corporation | $52.23 | 2025 | Artix Mt |
| Smith+Nephew, INC. | $52.08 | 2019-2022 | |
| Cook Medical LLC | $44.45 | 2019-2023 | Zenith |
| Kerecis Limited | $38.06 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Tactile Systems Technology INC | $33.67 | 2024 | Entre Plus, Flexitouch Plus |
| Boston Scientific Corporation | $30.66 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $24.17 | 2024 | Jobst Relief |
| Integra Lifesciences Corporation | $23.35 | 2021 | |
| Tei Biosciences INC | $20.22 | 2019 | |
| Tei Medical INC. | $19.78 | 2019 | |
| Biocompatibles, INC. | $18.32 | 2019 | |
| Allergan, INC. | $16.58 | 2020 | |
| Bolton Medical INC | $10.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sacca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.